Appili Therapeutics Inc. (TSX:APLI)
Canada flag Canada · Delayed Price · Currency is CAD
0.0200
-0.0050 (-20.00%)
At close: Feb 9, 2026

Appili Therapeutics Balance Sheet

Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Cash & Equivalents
0.351.230.092.476.6611.06
Short-Term Investments
-----5.06
Cash & Short-Term Investments
0.351.230.092.476.6616.12
Cash Growth
-47.58%1199.83%-96.17%-63.00%-58.67%52.98%
Other Receivables
0.21.671.170.421.391.69
Receivables
0.21.671.170.421.391.69
Prepaid Expenses
0.190.110.190.230.180.45
Total Current Assets
0.743.011.463.128.2418.26
Property, Plant & Equipment
0.010.020.030.010.040.05
Total Assets
0.753.031.493.138.2818.32
Accounts Payable
4.034.024.112.756.384.45
Accrued Expenses
0.090.090.080.080.070.08
Current Portion of Long-Term Debt
11.6111.567.310.110.10.09
Current Income Taxes Payable
0.020.030.050.04--
Total Current Liabilities
15.7515.6911.542.986.674.62
Long-Term Debt
0.610.740.887.554.880.95
Total Liabilities
16.3616.4312.4210.5311.555.56
Common Stock
42.3242.3242.3242.3239.6534.96
Additional Paid-In Capital
15.4614.8212.876.415.012.55
Retained Earnings
-73.96-71.72-69.09-65.31-56.07-30.95
Comprehensive Income & Other
0.561.182.989.188.136.19
Shareholders' Equity
-15.61-13.4-10.92-7.4-3.2712.75
Total Liabilities & Equity
0.753.031.493.138.2818.32
Total Debt
12.2212.298.187.674.981.03
Net Cash (Debt)
-11.87-11.07-8.09-5.21.6915.09
Net Cash Growth
-----88.83%58.28%
Net Cash Per Share
-0.10-0.09-0.07-0.050.030.26
Filing Date Shares Outstanding
121.27121.27121.27121.27121.2762.83
Total Common Shares Outstanding
121.27121.27121.27121.2771.2762.78
Working Capital
-15.01-12.68-10.080.141.5713.65
Book Value Per Share
-0.13-0.11-0.09-0.06-0.050.20
Tangible Book Value
-15.61-13.4-10.92-7.4-3.2712.75
Tangible Book Value Per Share
-0.13-0.11-0.09-0.06-0.050.20
Machinery
---0.060.130.14
Source: S&P Global Market Intelligence. Standard template. Financial Sources.